首页|不同入路腔镜甲状腺手术治疗甲状腺癌的临床效果分析

不同入路腔镜甲状腺手术治疗甲状腺癌的临床效果分析

Clinical effect analysis of endoscopic thyroid surgery for thyroid cancer through different approaches

扫码查看
目的 比较不同入路腔镜甲状腺手术对甲状腺癌患者临床效果的影响.方法 前瞻性纳入2020年1月至2023年1月山西省肿瘤医院头颈外科由同一经验丰富的手术团队实施完全腔镜甲状腺切除术(complete endoscopic thyroidectomy,CET)治疗甲状腺癌患者96例,随机数字表法分为经锁骨下组(经锁骨下入路CET)48例和经口组(经口腔前庭入路CET)48例.比较两组手术及术后康复情况、并发症、美容满意度评分,术前、术后1、3及7 d检测免疫指标[T淋巴细胞亚群(CD3+、CD4+)、CD4+/CD8+]、血清可溶性白细胞介素 2 受体(soluble interleukin 2 receptor,SIL-2R)、组织激肽释放酶 11(kallikrein11,KLK11)、中期因子(mid-kine,MK)水平,术后1、3及7 d采用视觉模拟量表(visual analog scale,VAS)、颈部损伤指数、吞咽障碍指数评估颈部功能.结果 经口组与经锁骨下组手术时间分别为(117.58±10.87)min和(101.84±11.35)min(P<0.001),住院时间分别为(4.31±0.86)d 和(5.12±0.91)d(P<0.001),引流量分别为(65.13±12.49)mL 和(78.65±15.32)mL(P<0.001).术后 1、3及7 d,经口组和经锁骨下组CD3+分别为(41.53±3.86)%和(38.29±3.51)%(P<0.001),(46.21±4.35)%和(42.81±4.06)%(P=0.001),(48.23±4.47)%和(45.10±4.23)%(P<0.001);CD4+水平分别为(33.27±3.90)%和(30.18±3.45)%(P<0.001),(36.28±4.15)%和(33.46±3.87)%(P=0.001),(38.69±4.22)%和(35.17±4.10)%(P<0.001);CD4+/CD8+水平分别为(1.31±0.22)和(1.16±0.21)(P=0.001),(1.40±0.23)和(1.20±0.22)(P<0.001),(1.58±0.24)和(1.45±0.25)(P=0.011).术后 1、3及7 d,经口组与经锁骨下组血清SIL-2R、KLK11、MK水平、VAS评分、颈部损伤指数、吞咽障碍指数相比,差异无统计学意义(P>0.05).经口组和经锁骨下组并发症发生率分别为8.33%(4/48)和22.92%(11/48)(P=0.049),美容满意度分别为95.83%(46/48)和81.25%(39/48)(P=0.025).结论 经口腔前庭入路与经锁骨下入路行CET治疗甲状腺癌均对颈部功能造成损伤,前者能减轻免疫功能损伤,有助于术后早期病情恢复,同时能提高安全性及患者美容满意度,但会延长手术时间.
Objective To compare the clinical effects of endoscopic thyroidectomy with different ap-proaches on patients with thyroid cancer.Methods A prospective study was conducted on 96 patients with thy-roid cancer who underwent complete endoscopic thyroidectomy(CET)by the same experienced surgical team in the Head and Neck Surgery Department of Shanxi Cancer Hospital from Jan.2020 to Jan.2023.The patients were randomly divided into a trans-subclavian approach group of 48 cases and a transoral vestibular access group of 48 cases using a random number table method.The trans-subclavian approach group underwent CET via the subclavi-an approach,while the transoral vestibular access group underwent CET via the oral vestibular approach.The surgi-cal and postoperative rehabilitation conditions,complications,and cosmetic satisfaction scores were compared be-tween the two groups.The immune indicators(T lymphocyte subsets(CD3+,CD4+),CD4+/CD8+),serum soluble in-terleukin 2 receptor(SIL-2R),tissue kallikrein 11(KLK11),midkine(MK)levels were measured before surgery.At 1 d,3 d,and 7 d postoperatively,neck function was assessed using the visual analog scale(VAS),neck injury index,and dysphagia index.Results The operation time of the transoral vestibular access group and the Trans-subclavian approach group were(117.58±10.87)min and(101.84±1 1.35)min,respectively(P<0.001),and the hospitalization time was(4.31±0.86)d and(5.12±0.91)d,respectively(P<0.001).The drainage volume was(65.13±12.49)mL and(78.65±15.32)mL,respectively(P<0.001).At 1,3,and 7 days after surgery,the CD3+levels in the transoral vestibular access group and the trans-subclavian approach group were(41.53±3.86)%and(38.29±3.51)%,respectively(P<0.001),(46.21±4.35)%and(42.81±4.06)%,respectively(P=0.001),and(48.23±4.47)%and(45.10±4.23)%,respectively(P<0.001).The CD4+levels were(33.27±3.90)%and(30.18±3.45)%,respectively(P<0.001),(36.28±4.15)%and(33.46±3.87)%,respectively(P=0.001),and(38.69±4.22)%and(35.17±4.10)%,respectively(P<0.001).The CD4+/CD8+levels were(1.31±0.22)and(1.16±0.21),respectively(P=0.001),(1.40±0.23)and(1.20±0.22),respectively(P<0.001),and(1.58±0.24)and(1.45±0.25),respectively(P=0.011).There was no significant difference in the levels of serum SIL-2R,KLK11,MK,VAS scores,cervical injury index,or swallowing dysfunction index between the transoral vestibular access group and the trans-subclavian approach group on postoperative day 1,3,and 7(P>0.05).The incidence of complica-tions in the transoral vestibular access group and the trans-subclavian approach group was 8.33%(4/48)and 22.92%(11/48),respectively(P=0.049),and the cosmetic satisfaction rate was 95.83%(46/48)and 81.25%(39/48),respectively(P=0.025).Conclusions Both the transoral vestibular approach and the subclavian approach for CET treatment of thyroid cancer can cause damage to cervical function.The former can reduce immune function damage,help with early postoperative recovery,and improve safety and patient satisfaction with cosmetic appear-ance,but it can prolong the operation time.

Thyroid cancerComplete endoscopic thyroidectomySubclavian approachOral vestib-ular approachImmune functionNeck functionBeauty satisfaction

吴雪松、秦彦超、韩飞、丁炜、秦东广

展开 >

山西省肿瘤医院中国医学科学院肿瘤医院山西医院山西医科大学附属肿瘤医院头颈外科,太原 030000

甲状腺癌 完全腔镜甲状腺切除术 锁骨下入路 口腔前庭入路 免疫功能 颈部功能 美容满意度

山西省科技厅项目

202203021222388

2024

中华内分泌外科杂志
中华医学会

中华内分泌外科杂志

CSTPCD
影响因子:0.657
ISSN:1674-6090
年,卷(期):2024.18(4)